FDA Approved: NEURACEQ — Original Application (Lantheus Biosciences Ltd.)

View source ↗

Summary

FDA approved NEURACEQ (florbetaben F-18) for PET imaging to estimate beta-amyloid neuritic plaque density in adults with cognitive impairment who are being eval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia

Drugs mentioned

• NEURACEQ (Florbetaben F 18)

Snippet

ORIG AP for NEURACEQ (FLORBETABEN F 18)